Cargando…
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation
T and B lymphocyte subsets have been not univocally associated to Graft-versus-host disease (GVHD) and relapse of hematological malignancies after stem cell transplantation (SCT). Their sequential assessment together with B and T cell neogenesis indexes has been not thoroughly analysed in relation t...
Autores principales: | Skert, Cristina, Perucca, Simone, Chiarini, Marco, Giustini, Viviana, Sottini, Alessandra, Ghidini, Claudia, Martellos, Stefano, Cattina, Federica, Rambaldi, Benedetta, Cancelli, Valeria, Malagola, Michele, Turra, Alessandro, Polverelli, Nicola, Bernardi, Simona, Imberti, Luisa, Russo, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388479/ https://www.ncbi.nlm.nih.gov/pubmed/28399164 http://dx.doi.org/10.1371/journal.pone.0175337 |
Ejemplares similares
-
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
por: Malagola, Michele, et al.
Publicado: (2017) -
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Malagola, Michele, et al.
Publicado: (2014) -
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?
por: Farina, Mirko, et al.
Publicado: (2020) -
Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients
por: Malagola, Michele, et al.
Publicado: (2015) -
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
por: Malagola, M., et al.
Publicado: (2019)